Clinical trial
PUFA Augmentation in Treatment of Major Depression
NCT00067301 · National Center for Complementary and Integrative Health (NCCIH), NIH · Completed
Key facts
| NCT number | NCT00067301 |
|---|---|
| Title | PUFA Augmentation in Treatment of Major Depression |
| Official title | PUFA Augmentation in Treatment of Major Depression |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Major Depression |
| Intervention type | Drug |
| Interventions | Polyunsaturated Fatty Acids (PUFA), Citalopram |
| Enrollment | 60 |
| Start date | Sep 1, 2003 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Aug 15, 2003 |
| Last update posted | Jan 25, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: